In CaSki human cervical cancer cells S100A8/A9 treatment induces apoptosis and inhibits migration of CaSki cells; S100A8/A9 also reduced the expression of matrix metalloproteinase (MMP)-2 in CaSki cells [59]. Here, S100A8 is linked to cervical cancer.